Pharmaceuticals, Biotechnology and Life Sciences
Latest Patent to Complement Issued Claims on Viral Inhibition, Adaptive Immune Stimulation, and Brain Protection/Regeneration ELK CITY, Idaho–(BUSINESS WIRE)–Therapeutic Solutions…
DUBLIN–(BUSINESS WIRE)–The “Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024” report has been added to ResearchAndMarkets.com’s offering.…
The rapid growth of Lantern Pharma’s AI platform could lead to accelerated development of better treatments, greater precision in clinical…
Two late-breaking abstracts have been accepted for oral presentation, including randomized studies evaluating ruxolitinib cream (Opzelura®) in hidradenitis suppurativa and…
MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services…
NEW YORK–(BUSINESS WIRE)–#biotech—Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President…
Ongoing Phase 1/2 clinical trial for NGN-401 to include additional patients in Cohort 1 and a dose-escalation cohort Both previously…
Dr. Lee brings over 20 years of biotechnology industry and Wall Street experience SKILLMAN, N.J.–(BUSINESS WIRE)–#4MT2001–4M Therapeutics Inc., an early-stage…
TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain…
– Orally administered SAT-3247 demonstrates efficacy across three mouse models of muscle degeneration – Efficacy in muscle injury model demonstrates…